Open Accessibility Menu

Mardi Gomberg-Maitland, MD,MSc

Need an Appointment ?
Contact (202) 795-2792
Mardi Gomberg-Maitland MD,MSc Mardi Gomberg-Maitland MD,MSc



  • Professor of Medicine | Medical Director, Pulmonary Hypertension Program
Medical Biography
  • Medical School
    • Albert Einstein College of Medicine, Yeshiva University
  • Residency
    • New York Presbyterian Hospital, Weill-Cornell Medical Center - Internal Medicine
  • Fellowship
    • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center - Cardiovascular Diseases
Board Certified
  • Internal Medicine
  • Cardiovascular Disease

Mardi Gomberg-Maitland, MD, MSc is a cardiologist and Professor of Medicine at the GW School of Medicine & Health Sciences. She also serves as the Medical Director of the MFA/GWUH Pulmonary Hypertension Program and will build a comprehensive management program to include outpatient and inpatient diagnosis and treatment, noninvasive and invasive testing, and state of the art Pulmonary Hypertension medication options.

Dr. Gomberg-Maitland completed her Medical Degree at Albert Einstein College of medicine, Yeshiva University, with a special distinction for Research in Cardiovascular Medicine, 1996. She completed her Residency in Internal Medicine at New York Presbyterian Hospital, Weill-Cornell Medical Center, 1999 and was accepted for Fellowship in Cardiovascular Diseases in 2002, at The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center. For the period of 2001-2002, Dr. Gomberg-Maitland was also a Visiting Fellow in Critical Care Medicine at the New York Presbyterian Hospital/Weill-Cornell Medical Center. She is boarded in Internal Medicine, Cardiovascular Disease and is licensed in the state of New York, Illinois and the Commonwealth of Virginia.

Dr. Gomberg-Maitland is an expert clinician and researcher in the field of Pulmonary Heart Disease. She has participated in dozens of multicenter, multinational research trials to explore new therapies for Pulmonary Hypertension. She is currently focusing on Pulmonary Arterial, Pulmonary Venous Hypertension/Diastolic Dysfunction, and Biomarker Development.

Dr. Gomberg-Maitland is nationally known for her work, has had extensive grant funding and is extensively published with over 150 articles, abstracts, reviews and chapters. She has published in peer-reviewed journals, including the Journal of the American College of Cardiology, JACC Heart Failure, Pulmonary Circulation, European Respiratory Journal, Chest, and the Journal of Heart and Lung Transplantation.


Sitbon O, Gomberg-Maitland M, Granton J, Lewis MI, Mathai SC, Rainisio M, Stockbridge NL, Wilkins MR, Zamanian RT, Rubin LJ. Clinical trial design and new therapies for pulmonary arterial hypertension. Eur Resp J. 2019 Jan 24;53(1) pii:1801908. Dec. 13. (epub) PMID: 30545975

Benza RL, Gomberg-Maitland M, Elliott G, Farber HWA, Foreman AJ, Frost AE, McGoon MD, Pasta DJ, Selej M, Burger C, Frantz RP. An update of the risk score calculator in pulmonary arterial hypertension patients from the registry to evaluate early and long-term PAH disease management (REVEAL). Chest. 2019 Feb 14 (epub)